There were a few minor side effects early on, but they faded quickly
MDL 3094 Status (January 2026): Presiding Judge: Hon
GLP-1s are shown to be effective for weight loss, but tracking muscle-mass retention has remained a missing piece until now, Nooms CEO says Noom is adding in-app body scan technology that will help GLP-1 users measure important body composition metrics, track progress, and monitor possible muscle mass loss
Here's what the trials have shown: Phase 1b Trial Results (Lancet 2022) The initial Phase 1b study evaluated retatrutide safety, tolerability, and pharmacokinetics in 72 adults with type 2 diabetes over 12 weeks
This setup enables direct characterization of all types of compounds acting on Gs-coupled receptors in either adherent or suspension cells
These discrepancies may stem from short observation periods and small sample sizes respectively (101, 102)